story of the week
Lapatinib or Trastuzumab Plus Taxane Therapy for HER2-Positive Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology